NF1-Associated PN Community Insights: Key Questions, Expert Answers
This 30-minute live social event features two expert faculty members leading an interactive discussion focused on the care of patients with neurofibromatosis…
This 30-minute live social event features two expert faculty members leading an interactive discussion focused on the care of patients with neurofibromatosis…
Richard J. Bleicher, MD, FACS, Chief of the Division of Breast Surgery and Clinical Director of the Breast Service Line at Fox Chase Cancer Center.
Help The Skin Cancer Foundation purchase and customize a new RV to keep our Destination Healthy Skin program on the road.
A BLA has been accepted by the FDA for 2 belantamab mafodotin combinations that have shown positive results in patients with multiple myeloma.
Testing for inherited cancer risk has become more accessible, affordable and accurate. Fred Hutch clinicians and researchers explain why it can be important, how to…
Health Canada has approved cilta-cel for use in patients with relapsed/lenalidomide-refractory multiple myeloma following 1 to 3 prior lines of therapy.
A quasi-experimental study sought to compare the 2 blood specimen collection methods to determine if one performed better for patients with central venous access devices.
AbstractBackground. Despite the increasing integration of wearable technology in oncology, its application in the care of older adults, representing most p
At TEDMED 2020 (March 3), Virologist and London School of Hygiene & Tropical Medicine Director Peter Piot sat down for a Q & A with…
wednesday, february 26 continental breakfast 7-8 a.m. Keynote Session 4Β 8-8:30 a.m. Session Chair: Antoni Ribas, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California education…
Learn how diabetic eye disease can cause vision loss.Version of this video with audio description: https://youtu.be/m4h43UIKqs4Vea la versiΓ³n de este video e…